Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of bambi as a marker for nasopharyngeal carcinoma

A technology of nasopharyngeal carcinoma and primer pair, applied in the field of detection, can solve problems such as rarely used clinical applications

Active Publication Date: 2021-01-15
ZHONGSHAN TRADITIONAL CHINESE MEDICINE HOSPITAL
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Other molecular markers identified as nasopharyngeal carcinoma are rarely used in clinical applications

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of bambi as a marker for nasopharyngeal carcinoma
  • Application of bambi as a marker for nasopharyngeal carcinoma
  • Application of bambi as a marker for nasopharyngeal carcinoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] The content of the present invention will be further described below in conjunction with specific experiments. For the experimental methods that do not indicate specific conditions in the following experiments, generally follow the conventional conditions, such as the conditions described in the "Molecular Cloning Experiment Guide" (Third Edition), or the conditions suggested by the manufacturer.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of BAMBI as a nasopharyngeal carcinoma maker. Through experiment researches by an applicant and a whole team for three years, researches on tissues and serums of 38 nasopharyngeal carcinoma patients, 12 chronic nasopharyngitis patients and 49 healthy volunteers are carried out, the researches show that the nasopharyngeal tissue BAMBI expression amount of the nasopharyngeal carcinoma patients is obviously increased, the expression amount of nasopharyngitis (nasopharyngitis is common benign disease) is relatively low, wherein p equals 0.0038, and the difference between nasopharyngeal carcinoma and nasopharyngitis is obvious. The serum BAMBI of the nasopharyngeal carcinoma patients is obviously increased, through statistical analysis, t equals 2.639, and p equals 0.012. No matter in nasopharyngeal carcinoma tissue or nasopharyngeal carcinoma serum, BAMBI presents up-regulated expression, so that the detection of BAMBI can be taken as a nasopharyngeal carcinoma molecular screening index.

Description

technical field [0001] The invention belongs to the detection field, and in particular relates to the application of BAMBI as a nasopharyngeal carcinoma marker. Background technique [0002] The transmembrane inhibitor (BMP and activin membrane—boundinhibitor, BAMBI) of bone morphogenic protein and activin is a kind of transmembrane glycoprotein, and BAMBI gene is by Onichtchouk etc. (Onichtchouk D, Chen YG, Dosch R, el a1.Silencing of TGF-beta signaling by the pseudoreceptor BAMBI.Nature, 1999, 401(6752): 480-485) was discovered in 1999, located in the p12.3-pl1.2 region of chromosome 10, and the encoded product is a 260-amino acid It is a transmembrane glycoprotein with a molecular weight of 29108kD, also known as a pseudoreceptor (Pseudoreceptor), which is compatible with the extracellular domains of type I receptors of ligands such as bone morphogenetic protein (BMP) and activin (activin). With a similar structure, BAMBI competes with TGF-β type I receptors for ligand b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6886
CPCC12Q1/6886C12Q2600/118C12Q2600/158
Inventor 周小军
Owner ZHONGSHAN TRADITIONAL CHINESE MEDICINE HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products